Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.

MLA

Forster, Angus H., et al. “Safety, Tolerability, and Immunogenicity of Influenza Vaccination with a High-Density Microarray Patch: Results from a Randomized, Controlled Phase I Clinical Trial.” PLoS Medicine, vol. 17, no. 3, Mar. 2020, pp. 1–31. EBSCOhost, https://doi.org/10.1371/journal.pmed.1003024.

APA

Forster, A. H., Witham, K., Depelsenaire, A. C. I., Veitch, M., Wells, J. W., Wheatley, A., Pryor, M., Lickliter, J. D., Francis, B., Rockman, S., Bodle, J., Treasure, P., Hickling, J., & Fernando, G. J. P. (2020). Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial. PLoS Medicine, 17(3), 1–31. https://doi.org/10.1371/journal.pmed.1003024

Chicago

Forster, Angus H., Katey Witham, Alexandra C. I. Depelsenaire, Margaret Veitch, James W. Wells, Adam Wheatley, Melinda Pryor, et al. 2020. “Safety, Tolerability, and Immunogenicity of Influenza Vaccination with a High-Density Microarray Patch: Results from a Randomized, Controlled Phase I Clinical Trial.” PLoS Medicine 17 (3): 1–31. doi:10.1371/journal.pmed.1003024.